Assessing the real-world effectiveness of the rVSV-ZEBOV vaccine

^*Corresponding author for this work

Research output: Contribution to journal › Comment/debate › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{3f34d21e2027474e999a28717f14837c,

title = "Assessing the real-world effectiveness of the rVSV-ZEBOV vaccine",

author = "Williamson, {Deborah A} and Thomson, {Emma C}",

year = "2024",

month = dec,

doi = "10.1016/S1473-3099(24)00437-7",

language = "English",

volume = "24",

pages = "1295--1296",

journal = "Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - Assessing the real-world effectiveness of the rVSV-ZEBOV vaccine

AU - Williamson, Deborah A

AU - Thomson, Emma C

PY - 2024/12

Y1 - 2024/12

U2 - 10.1016/S1473-3099(24)00437-7

DO - 10.1016/S1473-3099(24)00437-7

M3 - Comment/debate

C2 - 39178865

SN - 1473-3099

VL - 24

SP - 1295

EP - 1296

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

IS - 12

ER -